White House denies reports Trump received Eli Lilly's unapproved obesity drug retatrutide through an FDA program.

A stunning report reveals the president may have gotten an early access to an obesity drug to treat major medical issues.

Questions are swirling over Donald Trump’s health after a bombshell report revealed a mystery man was getting unprecedented access to a weight-loss drug.

Compassionate use of retatrutide granted for someone with sleep apnea, pulmonary hypertension